• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Comprehensive analysis of serum proteins associated with cancer metastasis and their clinical significance in colorectal cancer.

Research Project

Project/Area Number 21791280
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Digestive surgery
Research InstitutionMie University

Principal Investigator

TOIYAMA Yuji  Mie University, 大学院・医学系研究科, 助教 (00422824)

Project Period (FY) 2009 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Keywords大腸癌 / 予後因子 / サイトカイン / ケモカイン / 遠隔転移 / 血清予後因子 / 上皮間葉移行 / 予後マーカー
Research Abstract

The aim of this study is to identify novel and reliable serum markers related to the prognosis of colorectal cancer (CRC) patients and to assess the association between selected markers and clinical outcome. We identified HGF and several chemokines as novel prognostic markers in CRC patients and they significantly correlated with vascular metastasis, such as liver or lung metastasis. Serum HGF predicts poor prognosis patients in colorectal cancer with curative intent and that high expression of several serum chemokines are induced by secretion from target organs, such as liver or lung, in a paracrine fashion and showed the revelation of the metastatic destination for CRC and allows the progression of cancer cells in these metastatic sites.

Report

(3 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • Research Products

    (18 results)

All 2011 2010 2009

All Journal Article (11 results) (of which Peer Reviewed: 6 results) Presentation (5 results) Book (2 results)

  • [Journal Article] Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.2010

    • Author(s)
      Okugawa Y, Miki C, Toiyama Y, et al.
    • Journal Title

      Br J Cancer. 103(6)

      Pages: 787-795

    • Related Report
      2010 Final Research Report
  • [Journal Article] Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.2010

    • Author(s)
      Saigusa S, Toiyama Y, et al.
    • Journal Title

      Ann Surg Oncol. 17(8)

      Pages: 2051-2058

    • Related Report
      2010 Final Research Report
  • [Journal Article] Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma.2010

    • Author(s)
      Toiyama Y, Miki C, et al.
    • Journal Title

      Surg Today. 40(1)

      Pages: 46-53

    • NAID

      10027393728

    • Related Report
      2010 Final Research Report
  • [Journal Article] Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.2010

    • Author(s)
      Okugawa Y
    • Journal Title

      Br J cancer

      Volume: 103 Pages: 787-795

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.2010

    • Author(s)
      Saigusa S
    • Journal Title

      Ann Surg Oncol

      Volume: 17 Pages: 2051-2058

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma.2010

    • Author(s)
      Toiyama Y
    • Journal Title

      Surg Today

      Volume: 40 Pages: 46-53

    • NAID

      10027393728

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.2009

    • Author(s)
      Toiyama Y, Miki C, Inoue Y, Okugawa Y, Tanaka K, Kusunoki M.
    • Journal Title

      Int J Cancer. 125(7)

      Pages: 1657-1662

    • Related Report
      2010 Final Research Report
  • [Journal Article] Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma.2009

    • Author(s)
      Okugawa Y, Miki C, Toiyama Y, et al.
    • Journal Title

      Dis Colon Rectum. 52(7)

      Pages: 1330-1336

    • Related Report
      2010 Final Research Report
  • [Journal Article] Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma.2009

    • Author(s)
      Okugawa Y, Miki C, Toiyama Y
    • Journal Title

      Dis Colon Rectum 52

      Pages: 1330-1336

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.2009

    • Author(s)
      Toiyama Y, Miki C, Inoue Y
    • Journal Title

      Int J Cancer 125

      Pages: 1657-1662

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Circulating form of human vascular adhesion protein-1 (VAP-1) : decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.2009

    • Author(s)
      Toiyama Y, Miki C, Inoue Y
    • Journal Title

      J Surg Oncol 99

      Pages: 368-372

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Presentation] Use of serum CXCL16 to predict liver metastasis and prognosis in colorectal cancer patients.2011

    • Author(s)
      Matsushita K, Toiyama Y, et al
    • Organizer
      ASCO GI cancer meeting.
    • Place of Presentation
      San Francisco.
    • Year and Date
      2011-01-22
    • Related Report
      2010 Final Research Report
  • [Presentation] Evaluation of serum CXCL5 as a serum marker for prognosis of colorectal cancer patients.2011

    • Author(s)
      Kawamura M, Toiyama Y, et al
    • Organizer
      ASCO GI cancer meeting.
    • Place of Presentation
      San Francisco.
    • Year and Date
      2011-01-22
    • Related Report
      2010 Final Research Report
  • [Presentation] Use of serum CXCL16 to predict liver metastasis and prognosis in colorectal cancer patients.2011

    • Author(s)
      松下航平
    • Organizer
      ASCO GI cancer meeting
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-01-22
    • Related Report
      2010 Annual Research Report
  • [Presentation] Evaluation of serum CXCL5 as a serum marker for prognosis of colorectal cancer patients.2011

    • Author(s)
      川村幹雄
    • Organizer
      ASCO GI cancer meeting
    • Place of Presentation
      San Francisco
    • Year and Date
      2011-01-22
    • Related Report
      2010 Annual Research Report
  • [Presentation] Serum hepatocyte growth factor as a potent prognostic marker for colorectal cancer patients undergoing surgery with curative intent.2009

    • Author(s)
      Toiyama Y, et al
    • Organizer
      ASCO GI cancer meeting.
    • Place of Presentation
      San Francisco.
    • Year and Date
      2009-01-17
    • Related Report
      2010 Final Research Report
  • [Book] 大腸疾患NOW 20112011

    • Author(s)
      問山裕二, ら
    • Publisher
      日本メディカルセンター
    • Related Report
      2010 Final Research Report
  • [Book] 大腸疾患NOW 20112011

    • Author(s)
      問山裕二
    • Total Pages
      124
    • Publisher
      日本メディカルセンター
    • Related Report
      2010 Annual Research Report

URL: 

Published: 2009-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi